e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Sarcoidosis, interstitial lung diseases and various clinical problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Follow up of high-risk individuals with lung nodules identified on a CT-screening programme
M. Stolbrink (Liverpool, United Kingdom), B. Sedgwick (Liverpool, United Kingdom), R. Penfold (Liverpool, United Kingdom), L. Root (Liverpool, United Kingdom), G. Jones (Liverpool, United Kingdom)
Source:
International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Session:
Sarcoidosis, interstitial lung diseases and various clinical problems
Session type:
Thematic Poster
Number:
4109
Disease area:
Interstitial lung diseases, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Stolbrink (Liverpool, United Kingdom), B. Sedgwick (Liverpool, United Kingdom), R. Penfold (Liverpool, United Kingdom), L. Root (Liverpool, United Kingdom), G. Jones (Liverpool, United Kingdom). Follow up of high-risk individuals with lung nodules identified on a CT-screening programme. 4109
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Risk factors and prognosis of non-solid nodules in a lung cancer screening program
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019
Early lung cancer: Results of 17 years close surveillance in two high-risk cohorts
Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy
Year: 2010
Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
The efficacy of COPD detection by using a community-based annual screening program for lung cancer
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012
Smoking habits are unaffected by CT screening at 1 year follow up in the Danish lung cancer screening trial (DLCST)
Source: Annual Congress 2008 - Towards smoking cessation
Year: 2008
Use of NELSON screening to early detect lung cancer(LC) patients in the Portuguese population
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screening
Source: Eur Respir J, 54 (2) 1802221; 10.1183/13993003.02221-2018
Year: 2019
Invasive exercise testing in the evaluation of patients at high-risk for lung resection
Source: Guideline 1998
Year: 1998
Management of incidental nodules in lung cancer screening: ready for prime-time?
Source: Breathe, 15 (4) 346; 10.1183/20734735.0247-2019
Year: 2019
Case-finding for COPD: Developing strategies to identify patients at risk populations
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up?
Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020
Year: 2020
Prevalence and burden of bronchiectasis in a lung cancer screening program
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Early diagnosis of COPD in a high-risk population using spirometric screening in general practice
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011
Follow up of surgically treated non small cell lung cancer patients: which modalities?
Source: Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment
Year: 2008
Follow -up results, malignancy rates and malignancy determinants of the pulmonary nodules that evaluated in multidisciplinary thoracic oncology tumour board
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Validation of the COPD lung cancer screening score in a community based cohort of COPD patients
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Patients referred to a lung cancer clinic – does a clinical assessment at the outset have an impact on the investigations requested?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Minimally-invasive investigation for lung cancer in a high-risk cohort
Source: Annual Congress 2013 –Early detection of lung cancer
Year: 2013
Screening for lung cancer
Source: Eur Respir Mon; 2009: 44: 57–70
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept